A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering,Biotechnology Progress

当前位置： X-MOL 学术 › Biotechnol. Prog. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
Biotechnology Progress ( IF 2.9 ) Pub Date : 2021-09-19 , DOI: 10.1002/btpr.3212
Joseph Carver ₁ , Marie Kern ₁ , Peggy Ko ₁ , Midori Greenwood-Goodwin ₂ , X Christopher Yu ₂ , Dana Duan ₁ , Danming Tang ₁ , Shahram Misaghi ₁ , Simon Auslaender ₃ , Ben Haley ₄ , Inn H Yuk ₁ , Amy Shen ₁

Affiliation

Chinese hamster ovary (CHO) cell engineering based on CRISPR/Cas9 knockout (KO) technology requires the delivery of guide RNA (gRNA) and Cas9 enzyme for efficient gene targeting. With an ever-increasing list of promising gene targets, developing, and optimizing a multiplex gene KO protocol is crucial for rapid CHO cell engineering. Here, we describe a method that can support efficient targeting and KO of up to 10 genes through sequential transfections. This method utilizes Cas9 protein to first screen multiple synthetic gRNAs per gene, followed by Sanger sequencing indel analysis, to identify effective gRNA sequences. Using sequential transfections of these potent gRNAs led to the isolation of single cell clones with the targeted deletion of all 10 genes (as confirmed by Sanger sequencing at the DNA level and mass spectrometry at the protein level). Screening 704 single cell clones yielded 6 clones in which all 10 genes were deleted through sequential transfections, demonstrating the success of this decaplex gene editing strategy. This pragmatic approach substantially reduces the time and effort required to generate multiple gene knockouts in CHO cells.

更新日期：2021-09-19

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>